New research
suggests that public health officials must respond to
concerns about stigma and vaccine-induced infection if women
are to take full advantage of eventual HIV vaccines,
Women's Health Weekly reports. Peter A.
Newman of the University of Toronto and colleagues
from the University of California, Los Angeles, and the
Los Angeles County Health Department conducted a series of
focus groups with health care providers and women from
at-risk populations in Los Angeles.
As disincentives
to immunization, the women reported they worried about
being labeled gay or promiscuous if they took the vaccine,
contracting HIV/AIDS from the vaccine, power dynamics
(the influence of husbands in denial about their own
risky behaviors), affordability, reproductive side
effects, and discrimination in obtaining the vaccine.
On the other
hand, the women identified strong motivations for getting
vaccinated, including empowerment to protect themselves
against HIV. Others wanted to ensure their children
would be protected.
Women and health
care providers suggested the vaccine be delivered as
part of routine care, thus avoiding having to confront their
partners, and removing the stigma of obtaining care
from HIV-identified services. "Vaccines must be easy
to obtain and affordable and women's particular
concerns must be addressed, or HIV vaccines will have
limited success among the people most vulnerable to
infection," Newman said. He noted that the first
generation of HIV vaccines could be available within
10 years.